Baillie Gifford & CO Penumbra Inc Transaction History
Baillie Gifford & CO
- $131 Billion
- Q3 2024
A detailed history of Baillie Gifford & CO transactions in Penumbra Inc stock. As of the latest transaction made, Baillie Gifford & CO holds 591,846 shares of PEN stock, worth $146 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
591,846
Previous 614,863
3.74%
Holding current value
$146 Million
Previous $111 Million
3.85%
% of portfolio
0.09%
Previous 0.09%
Shares
29 transactions
Others Institutions Holding PEN
# of Institutions
374Shares Held
29.2MCall Options Held
305KPut Options Held
192K-
Black Rock Inc. New York, NY4.26MShares$1.05 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.68MShares$909 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.99MShares$491 Million0.04% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.55MShares$383 Million1.9% of portfolio
-
State Street Corp Boston, MA1.24MShares$306 Million0.01% of portfolio
About Penumbra Inc
- Ticker PEN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,888,400
- Market Cap $9.37B
- Description
- Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...